Site menu

Search by ticker code:
Generic filters

Menu

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Invocare (ASX:IVC) share price soars on new takeover offer

The Invocare Limited (ASX: IVC) share price has jumped 12% higher after receiving and accepting an improved takeover offer.

Invocare is the largest funeral business in Australia and New Zealand.

Takeover offer accepted

The funeral business said that it has received a revised, non-binding indicative proposal from TPG.

This higher offer is $13 per share, including a fully franked special dividend of up to approximately $0.60 per share. For Invocare shareholders that can utilise franking credits, this represents a total value of up to approximately $13.25 per share.

Invocare has agreed to let TPG undertake due diligence (check the financial numbers) on an exclusive basis so that it can then provide a binding proposal.

If the proposal becomes a binding transaction, then Invocare’s board intends to unanimously recommend it to shareholders.

This revised offer comes after the board’s engaging with TPG since the initial offer of $12.65 per share on 7 March 2023. Shareholders and the Invocare share price has benefited from the board’s persistence.

But, there are still a number of conditions including completing satisfactory due diligence final approval by TPG’s investment review committee, entry into an acceptable takeover deal, and a unanimous recommendation from the Invocare board of directors that shareholders vote in favour of the deal.

Is this a done deal?

Invocare noted that there is no certainty at this stage that the revised offer will result in a binding scheme implementation deed for consideration by shareholders.

But, the market seems fairly confident of this going through with the Invocare share price only being 5% lower than the offer price. That’s quite good/close considering the risk-free return that investors could get by having their money in cash to the time of a possible takeover being completed.

Final thoughts on the Invocare share price

It’d be a shame to lose Invocare from the ASX boards considering the business is (morbidly) exposed to long-term tailwinds with Australia’s ageing demographics. But, the rise in the last few months has been helpful.

If I were a shareholder, I’d be happy to sell now because there’s a chance that TPG could decide to walk away rather than follow through with a takeover.

By selling shares, one could then invest the money into attractive, long-term ASX dividend shares.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content